Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-10024Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-13391Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-13522Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-13846Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-14378Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-19866Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-21132Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-21209Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-22085Peak area normalizedmale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-25953Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-30769Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-36463Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-37231Peak area normalizedmale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEDEOXYADENOSINE (M+CL)-45976Peak area normalizedfemale diabetic no neuropathy

Return to search page
  logo